Atlas Trials

Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients

Clinical trial NCT03573102 · UNKNOWN

Trial details

NCT number
NCT03573102
Sponsor
Nahla H Tohami
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetic Nephropathies
Start date
2018-06-20
Primary completion
2020-06-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.